![Health Conversation artwork](https://is4-ssl.mzstatic.com/image/thumb/Podcasts124/v4/28/fb/17/28fb171a-e14a-4d1b-a9cd-d18188cd6187/mza_10725344026324069.jpeg/100x100bb.jpg)
Is industry doing enough to tackle antimicrobial resistance?
Health Conversation
English - November 17, 2020 15:00 - 18 minutes - 41.5 MB - ★★★★★ - 1 ratingMedicine Health & Fitness Alternative Health health covid-19 r&d patients vaccines pharmaceutical pharma pharmaceutical industry research & development patient safety Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: How can Europe be better prepared for future pandemics?
Next Episode: Can we develop better medicines for children faster?
Welcome to 19 Conversations. Today we're asking Elizabeth Hermsen, Head of Global Antimicrobial Stewardship, MSD and Bruce Altevogt, Vice President and Head of External Medical Engagement, Hospital Business Unit, Pfizer "Is industry doing enough to tackle antimicrobial resistance?". Listen to hear their discussion on the challenge and how we're preparing for the future.
Hosted on Acast. See acast.com/privacy for more information.